Search for a doctor

Sindhuja Sominidi Damodaran, M.B.B.S., M.D.

  1. Dermatologist

Publications

  1. Akpala C, Kim G, Froehling D, Comfere N, Sominidi Damodaran S. Cholesterol Embolization Syndrome Post Invasive Arterial Procedure: A Case Report. Cureus. 2023 Oct; 15 (10):e46986 Epub 2023 Oct 13
    View PubMed
  2. Xie F, Sominidi-Damodaran S. Pityriasis Amiantacea. Mayo Clin Proc. 2022 Oct; 97 (10):1769-1770
    View PubMed
  3. Hieken TJ, Sadurni MB, Quattrocchi E, Kobic A, Sominidi-Damodaran S, Dwarkasing JT, Meerstein-Kessel L, Bridges AG, Meves A. Using the Merlin assay for reducing sentinel lymph node biopsy complications in melanoma: a retrospective cohort study. Int J Dermatol. 2022 Jul; 61 (7):848-854 Epub 2022 Jan 31
    View PubMed
  4. Kung FF, Arias-Mejias SM, Quattrocchi E, Sominidi-Damodaran S, Bridges AG, Lehman JS, Weaver AL, Meves A. PD-1, PD-L1, and BIM as Predictors of Sentinel Lymph Node Metastasis in Primary Cutaneous Melanoma. J Invest Dermatol 2020 Nov; 140 (11):2301-2304.e3 Epub 2020 Apr 08
    View PubMed
  5. Eggermont AMM, Bellomo D, Arias-Mejias SM, Quattrocchi E, Sominidi-Damodaran S, Bridges AG, Lehman JS, Hieken TJ, Jakub JW, Murphree DH, Pittelkow MR, Sluzevich JC, Cappel MA, Bagaria SP, Perniciaro C, Tjien-Fooh FJ, Rentroia-Pacheco B, Wever R, van Vliet MH, Dwarkasing J, Meves A. Identification of stage I/IIA melanoma patients at high risk for disease relapse using a clinicopathologic and gene expression model. Eur J Cancer. 2020 Nov; 140:11-18 Epub 2020 Oct 05
    View PubMed
  6. Quattrocchi E, Sominidi-Damodaran S, Murphree DH, Meves A. beta3 integrin immunohistochemistry as a method to predict sentinel lymph node status in patients with primary cutaneous melanoma. Int J Dermatol. 2020 Oct; 59 (10):1241-1248 Epub 2020 Aug 09
    View PubMed
  7. Arias-Mejias SM, Warda KY, Quattrocchi E, Alonso-Quinones H, Sominidi-Damodaran S, Meves A. The role of integrins in melanoma: a review. Int J Dermatol. 2020 May; 59 (5):525-534 Epub 2020 Mar 10
    View PubMed
  8. Bellomo D, Arias-Mejias SM, Ramana C, Heim JB, Quattrocchi E, Sominidi-Damodaran S, Bridges AG, Lehman JS, Hieken TJ, Jakub JW, Pittelkow MR, DiCaudo DJ, Pockaj BA, Sluzevich JC, Cappel MA, Bagaria SP, Perniciaro C, Tjien-Fooh FJ, van Vliet MH, Dwarkasing J, Meves A. Model Combining Tumor Molecular and Clinicopathologic Risk Factors Predicts Sentinel Lymph Node Metastasis in Primary Cutaneous Melanoma. JCO Precis Oncol. 2020; 4:319-334 Epub 2020 Apr 14
    View PubMed
  9. Lehman JS, Dasari S, Damodaran SS, El-Azhary RA, Gibson LE, Hashmi SK, Hogan WJ, Kenderian SJ, Patnaik MS, Litzow MR, Lazarus HM, Meves A. Differential expression of interferon-induced genes and other tissue-based biomarkers in acute graft-versus-host disease vs. lupus erythematosus in skin. Clin Exp Dermatol. 2019 Jun; 44 (4):e81-e88 Epub 2018 Oct 02
    View PubMed
  10. Heim JB, McDonald CA, Wyles SP, Sominidi-Damodaran S, Squirewell EJ, Li M, Motsonelidze C, Bottcher RT, van Deursen J, Meves A. FAK auto-phosphorylation site tyrosine 397 is required for development but dispensable for normal skin homeostasis. PLoS One. 2018; 13 (7):e0200558 Epub 2018 July 12
    View PubMed
  11. Sominidi-Damodaran S, Guo R, Meves A, Bridges AG. Expanded traditional melanoma FISH testing versus CAP-QPCR to identify high-risk melanocytic lesions. Int J Dermatol 2017 Sep; 56 (9):e182-e184 Epub 2017 Mar 20
    View PubMed
  12. Laniosz V, Onajin O, Sominidi-Damodaran S, Meves A, Gibson LE, Baum CL. Natural killer cell response is a predictor of good outcome in MCPyV+ Merkel cell carcinoma: A case series of 23 patients. J Am Acad Dermatol 2017 Jul; 77 (1):31-32 Epub 2017 Mar 25
    View PubMed
  13. Heim JB, Squirewell EJ, Neu A, Zocher G, Sominidi-Damodaran S, Wyles SP, Nikolova E, Behrendt N, Saunte DM, Lock-Andersen J, Gaonkar KS, Yan H, Sarkaria JN, Krendel M, van Deursen J, Sprangers R, Stehle T, Bottcher RT, Lee JH, Ordog T, Meves A. Myosin-1E interacts with FAK proline-rich region 1 to induce fibronectin-type matrix. Proc Natl Acad Sci U S A. 2017 Apr 11; 114 (15):3933-3938 Epub 2017 Mar 27
    View PubMed
  14. Sominidi-Damodaran S, Meves A. Cell adhesion phenotyping by quantitative polymerase chain reaction in melanoma: Clarifying misconceptions. J Am Acad Dermatol 2017 Jan; 76 (1):e23
    View PubMed
  15. Barrick BJ, Ida CM, Laniosz V, Jentoft ME, Sominidi-Damodaran S, Wieland CN, Meves A, Lehman JS. Bullous Pemphigoid, Neurodegenerative Disease, and Hippocampal BP180 Expression: A Retrospective Postmortem Neuropathologic Study. J Invest Dermatol 2016 Oct; 136 (10):2090-2092 Epub 2016 June 24
    View PubMed
  16. Sominidi-Damodaran S, Pittelkow MR, Meves A. Gene Expression Profiling in Cutaneous Melanoma: Caveats for Clinicians. Mayo Clin Proc 2016 Aug; 91 (8):1147-8
    View PubMed
  17. Sominidi-Damodaran S, Daniel SJ, Janaki C, Madhu S, Manjula J, Prabhavathy D, Arunadevi R, Jayakumar S. A study on chronic autoimmune urticaria and efficacy of autologous serum therapy The Tamilnadu Dr.M.G.R. Medical University E - Dissertation. 2012.
  18. Sominidi-Damodaran S, Tharani G, Jayakumar S. Dowling Degos Disease with Reticulate Acropigmentation of Kitamura a case report The Tamil Nadu Dr. M.G.R. Medical University. 2011.
PST-20550835